BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35103020)

  • 1. Relapse of Hepatitis C Virus Cryoglobulinemic Vasculitis After Sustained Viral Response After Interferon-Free Direct-Acting Antivirals.
    Fayed A; Hegazy MT; Biard L; Vieira M; El Shabony T; Saadoun D; Casato M; Visentini M; Ragab G; Cacoub P
    Am J Gastroenterol; 2022 Apr; 117(4):627-636. PubMed ID: 35103020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis.
    Cacoub P; Si Ahmed SN; Ferfar Y; Pol S; Thabut D; Hezode C; Alric L; Comarmond C; Ragab G; Quartuccio L; Hegazy M; Poynard T; Resche Rigon M; Saadoun D
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):518-526. PubMed ID: 29857143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryoglobulinemia vasculitis: how to handle.
    Desbois AC; Comarmond C; Saadoun D; Cacoub P
    Curr Opin Rheumatol; 2017 Jul; 29(4):343-347. PubMed ID: 28368978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of Cryoglobulinemia in Direct-Acting Antiviral-Treated Asian Hepatitis C Patients With Sustained Virological Responses: A 4-Year Prospective Cohort Study.
    Chang ML; Cheng JS; Chuang YH; Pao LH; Wu TS; Chen SC; Chang MY; Chien RN
    Front Immunol; 2022; 13():823160. PubMed ID: 35371039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis.
    Saadoun D; Pol S; Ferfar Y; Alric L; Hezode C; Si Ahmed SN; de Saint Martin L; Comarmond C; Bouyer AS; Musset L; Poynard T; Resche Rigon M; Cacoub P
    Gastroenterology; 2017 Jul; 153(1):49-52.e5. PubMed ID: 28288791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of Cryoglobulinemic Vasculitis after DAA Induced HCV Cure.
    Danishwar M; Jamil Z; Khan S; Nakhla M; Ahmad I; Ali MA; Lau DTY
    J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinico-immunological outcomes of HCV-cured cryoglobulinemia: Lower relapse rate with interferon-based than interferon-free therapy.
    Colantuono S; Marrapodi R; Del Padre M; Collalti G; Garzi G; De Santis A; Fiorilli M; Basili S; Visentini M; Casato M
    Liver Int; 2021 Jan; 41(1):70-75. PubMed ID: 33064930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and cost of hepatitis C virus cryoglobulinaemia vasculitis treatment: From interferon-based to direct-acting antivirals era.
    Cacoub P; Vautier M; Desbois AC; Lafuma A; Saadoun D
    Liver Int; 2017 Dec; 37(12):1805-1813. PubMed ID: 28467688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort.
    Kondili LA; Monti M; Quaranta MG; Gragnani L; Panetta V; Brancaccio G; Mazzaro C; Persico M; Masarone M; Gentile I; Andreone P; Madonia S; Biliotti E; Filomia R; Puoti M; Fracanzani AL; Laccabue D; Ieluzzi D; Coppola C; Rumi MG; Benedetti A; Verucchi G; Coco B; Chemello L; Iannone A; Ciancio A; Russo FP; Barbaro F; Morisco F; Chessa L; Massari M; Blanc P; Zignego AL
    Hepatology; 2022 Jul; 76(1):220-232. PubMed ID: 34919289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryoglobulinemia Vasculitis.
    Cacoub P; Comarmond C; Domont F; Savey L; Saadoun D
    Am J Med; 2015 Sep; 128(9):950-5. PubMed ID: 25837517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus-related cryoglobulinemic vasculitis.
    Mazzaro C; Mauro E; Ermacora A; Doretto P; Fumagalli S; Tonizzo M; Toffolutti F; Gattei V
    Minerva Med; 2021 Apr; 112(2):175-187. PubMed ID: 33198444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus-related vasculitis.
    Boleto G; Vieira M; Saadoun D; Cacoub P
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101575. PubMed ID: 33268038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term renal function alterations in hepatitis C patients with SVRs: Impacts of therapies and mixed cryoglobulinemia.
    Chang ML; Cheng JS; Chen WT; Hsu CW; Chen KH; Chen YC; Chien RN
    J Infect Public Health; 2024 Mar; 17(3):486-494. PubMed ID: 38280352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents.
    Roccatello D; Sciascia S; Rossi D; Solfietti L; Fenoglio R; Menegatti E; Baldovino S
    Oncotarget; 2017 Jun; 8(25):41764-41777. PubMed ID: 28454112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid improvement of psychiatric stigmata after IFN-free treatment in HCV patients with and without cryoglobulinemic vasculitis.
    Gragnani L; Lorini S; Martini L; Stasi C; Visentini M; Petraccia L; Marello N; Monti M; Marri S; Madia F; Ricca V; Zignego AL
    Clin Rheumatol; 2022 Jan; 41(1):147-157. PubMed ID: 34409558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus-induced vasculitis: therapeutic options.
    Cacoub P; Terrier B; Saadoun D
    Ann Rheum Dis; 2014 Jan; 73(1):24-30. PubMed ID: 23921995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of cryoglobulinemia and cryoglobulinemic vasculitis in chronically HCV-infected Brazilian patients.
    Aguiar MF; Faria-Janes AL; Garcia-Brandes GI; Takemi-Emori C; Ferraz MLG; Andrade LEC; de Souza AWS
    Ann Hepatol; 2019; 18(5):685-692. PubMed ID: 31167733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements.
    Dammacco F; Lauletta G; Vacca A
    Clin Exp Med; 2023 Jun; 23(2):255-272. PubMed ID: 35348938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Direct Acting Antivirals for the Treatment of Mixed Cryoglobulinemia.
    Emery JS; Kuczynski M; La D; Almarzooqi S; Kowgier M; Shah H; Wong D; Janssen HLA; Feld JJ
    Am J Gastroenterol; 2017 Aug; 112(8):1298-1308. PubMed ID: 28291241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure.
    Bonacci M; Lens S; Mariño Z; Londoño MC; Rodriguez-Tajes S; Sánchez-Tapias JM; Ramos-Casals M; Hernández-Rodríguez J; Forns X
    Gastroenterology; 2018 Aug; 155(2):311-315.e6. PubMed ID: 29705529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.